Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 41

1.

Lymphangioleiomyomatosis: what do we know and what are we looking for?

Harari S, Torre O, Moss J.

Eur Respir Rev. 2011 Mar;20(119):34-44. doi: 10.1183/09059180.00011010. Review.

2.

The changing face of a rare disease: lymphangioleiomyomatosis.

Harari S, Torre O, Cassandro R, Moss J.

Eur Respir J. 2015 Nov;46(5):1471-85. doi: 10.1183/13993003.00412-2015. Epub 2015 Sep 24. Review.

3.

Lymphangioleiomyomatosis - a wolf in sheep's clothing.

Henske EP, McCormack FX.

J Clin Invest. 2012 Nov;122(11):3807-16. doi: 10.1172/JCI58709. Epub 2012 Nov 1. Review.

4.

Molecular pathogenesis of lymphangioleiomyomatosis: lessons learned from orphans.

Juvet SC, McCormack FX, Kwiatkowski DJ, Downey GP.

Am J Respir Cell Mol Biol. 2007 Apr;36(4):398-408. Epub 2006 Nov 10. Review.

5.

Lymphatics in lymphangioleiomyomatosis and idiopathic pulmonary fibrosis.

Glasgow CG, El-Chemaly S, Moss J.

Eur Respir Rev. 2012 Sep 1;21(125):196-206. doi: 10.1183/09059180.00009311. Review.

6.

Smooth muscle-like cells in pulmonary lymphangioleiomyomatosis.

Krymskaya VP.

Proc Am Thorac Soc. 2008 Jan 1;5(1):119-26. Review.

7.

Lymphangioleiomyomatosis and tuberous sclerosis complex.

Chorianopoulos D, Stratakos G.

Lung. 2008 Jul-Aug;186(4):197-207. doi: 10.1007/s00408-008-9087-5. Epub 2008 Apr 12. Review.

PMID:
18408969
8.

Clinical and molecular insights into lymphangioleiomyomatosis.

Steagall WK, Taveira-DaSilva AM, Moss J.

Sarcoidosis Vasc Diffuse Lung Dis. 2005 Dec;22 Suppl 1:S49-66. Review.

PMID:
16457017
9.
10.

Lymphangioleiomyomatosis: Current understanding and potential treatments.

Moir LM.

Pharmacol Ther. 2016 Feb;158:114-24. doi: 10.1016/j.pharmthera.2015.12.008. Epub 2015 Dec 20. Review.

PMID:
26713679
11.

Lymphangioleiomyomatosis.

Ansótegui Barrera E, Mancheño Franch N, Vera-Sempere F, Padilla Alarcón J.

Arch Bronconeumol. 2011 Feb;47(2):85-93. doi: 10.1016/j.arbres.2010.08.008. Epub 2011 Jan 20. Review. English, Spanish.

12.

Minireview: Lymphangioleiomyomatosis (LAM): The "Other" Steroid-Sensitive Cancer.

Prizant H, Hammes SR.

Endocrinology. 2016 Sep;157(9):3374-83. doi: 10.1210/en.2016-1395. Epub 2016 Jul 13. Review.

13.

Metastasis of benign tumor cells in tuberous sclerosis complex.

Henske EP.

Genes Chromosomes Cancer. 2003 Dec;38(4):376-81. Review.

PMID:
14566858
14.

Optimizing treatments for lymphangioleiomyomatosis.

Taveira-DaSilva AM, Moss J.

Expert Rev Respir Med. 2012 Jun;6(3):267-76. doi: 10.1586/ers.12.26. Review.

15.

Extrapulmonary lymphangioleiomyomatosis and lymphangiomatous cysts in tuberous sclerosis complex.

Torres VE, Björnsson J, King BF, Kumar R, Zincke H, Edell ES, Wilson TO, Hattery RR, Gomez MR.

Mayo Clin Proc. 1995 Jul;70(7):641-8. Review.

PMID:
7791386
16.

Lymphangioleiomyomatosis: A Monogenic Model of Malignancy.

Krymskaya VP, McCormack FX.

Annu Rev Med. 2017 Jan 14;68:69-83. doi: 10.1146/annurev-med-050715-104245. Review.

17.

[Clinicopathologic analysis of pulmonary lymphangioleiomyomatosis].

Lü Y, Liao SL, Tang XN, Ye Q, Zhang L, Zhao HY.

Zhonghua Bing Li Xue Za Zhi. 2005 Feb;34(2):84-7. Review. Chinese.

PMID:
15842802
18.

Lymphangioleiomyomatosis.

Johnson SR.

Eur Respir J. 2006 May;27(5):1056-65. Review.

19.

Lymphangioleiomyomatosis.

Taveira-DaSilva AM, Steagall WK, Moss J.

Cancer Control. 2006 Oct;13(4):276-85. Review.

PMID:
17075565
20.

LAM cells biology and lymphangioleiomyomatosis.

Grzegorek I, Drozdz K, Podhorska-Okolow M, Szuba A, Dziegiel P.

Folia Histochem Cytobiol. 2013;51(1):1-10. doi: 10.5603/FHC.2013.001. Review.

Supplemental Content

Support Center